The Fullstack Investor
by Lin
v1.3
Explore
1
Watchlist
2
Themes
3
Live Feed
4
Dashboard
5
Earnings
6
TOols
Market Model
Start Here
Connect
Twitter
Login
L
Logout
X
Go Back
Company or ticker...
Enliven develops small molecule cancer drugs focused on genetically defined tumors.
Ticker
M. Cap
PS
PE
YTD
10MA
20MA
50MA
200MA
ELVN
3.8B
0.0
n/a
232.58%
Key Facts
Join Now
